| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.4 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |